February 11, 2022 Comments Off on New patent for Gilead Sciences drug STRIBILD Posted in: Patent Added Annual Drug Patent Expirations for STRIBILD Stribild is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent for Gilead Sciences drug STRIBILD appeared first on Dr…
February 11, 2022 Comments Off on New patent for Gilead Sciences drug GENVOYA Posted in: Patent Added Annual Drug Patent Expirations for GENVOYA Genvoya is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are thirteen…
The post New patent for Gilead Sciences drug GENVOYA appeared first on Drug…
